Behçet's Ocular Disease — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Systemic corticosteroids plus infliximab or adalimumab
Behçet's disease with anterior uveitis and hypopyon is a sight-threatening complication requiring aggressive systemic immunosuppression. Posterior uveitis/retinal vasculitis in Behçet's carries a high risk of visual loss. EULAR recommendations advise systemic corticosteroids combined with either azathioprine or anti-TNF therapy (infliximab or adalimumab) for sight-threatening eye disease. Topical steroids alone are insufficient. Colchicine is adequate for mucocutaneous disease but not for ocular involvement.
Reference: eTG – 2025 – Rheumatology; EULAR – 2018 – Behçet's Disease Recommendations